Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The Melanoma Research Alliance commits strategic research funding to improve the understanding about the causes of melanoma and to develop better treatments for this deadly disease.
Researchers are hard at work developing meaningful improvements through next-generation treatments that could improve patient outcomes.
After being melanoma-free for five years in 2000, McGowan began a 4,250-mile adventure from Oregon to the Atlantic Ocean in Virginia.
An interview with integrative medicine specialist Gary Deng, MD, MPH, on strengthening the body while managing treatment side effects.
Melanoma Research Alliance Board member Ellen Davis discusses how a sign at a dermatologist’s office convinced her to see a dermatologist.
Experts provide insights into expanding the effectiveness of new treatments for melanoma.
Margaret has never stopped living and enjoying her life despite her disease and the side effects of her medication.
Instead of researching new treatment targets or experimental combination therapies, she focuses on patient experience and quality of life.
Here are a few highlights related to melanoma from the first-ever Virtual AACR Annual Meeting and Virtual ASCO Annual Meeting.
What matters most to melanoma patients when it comes to participating in clinical trials?
Shirin Bajaj, MD, veered towards cancer research after the loss of her grandmother to the disease.
The 2020 MRA Scientific Retreat provides updates on the latest melanoma research.
“I was raised to believe that what a doctor says is sacrosanct, but I now understand how important it is to advocate for yourself.”
A black and white photo series explores the impact and meaning of melanoma research for patients and their loved ones.
“I’m really passionate about cancer biology and working on early detection in cancer,” says Aditi Sahu, a post-doctoral fellow at MSKCC.
After her own diagnosis, Melody Burchett founded A Cure In Sight, a non-profit organization raising ocular melanoma awareness.
The 26 awards will support research at 23 institutions in five countries.
L’Oréal Active Cosmetics Division and MRA team up to advance crucial research in skin cancer prevention and detection using AI technology.
Enrica Quattrocchi, MD, examines cutaneous melanoma by applying AI to distinguish between slow growing and aggressive melanomas.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.